APAC Hemodialysis and Peritoneal Dialysis Market
Asia Pacific Hemodialysis and Peritoneal Dialysis Market Size Set to Expand at Significant CAGR Touching USD 20 Billion by 2030
Published | 12 April 2024
Asia Pacific Hemodialysis and Peritoneal Dialysis Market is flourishing because of the rising prevalence of chronic kidney disease (CKD) and government initiatives on improving healthcare sector.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Hemodialysis and Peritoneal Dialysis Market size at USD 17.39 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Asia Pacific Hemodialysis and Peritoneal Dialysis Market size to expand at a CAGR of 6.85% reaching a value of USD 19.87 billion by 2030. Growing rates of diabetes and many other chronic kidney illnesses across the region are major growth factors for the Asia Pacific Hemodialysis and Peritoneal Dialysis Market. Furthermore, the market is expected to thrive substantially from the rapid adoption of technological advances and the growing integration of IoT in-home care for long-term patients over the period in analysis.
Opportunity: Growing elderly population across APAC countries
One of the major factors contributing to the growing prevalence of chronic kidney disease is older age. The growing geriatric population in the Asia Pacific countries is anticipated to increase the number of patients suffering from CKD in the region. Major Asian economies, including China, Japan, and South Korea, are registering rapid spike in its elderly population as a result of decline in fertility and mortality rates. This trend is also making waves in other countries as well, such as in Singapore, Thailand, and Taiwan. The rising aging population and increasing rate of CKD is anticipated to drive the Asia Pacific Hemodialysis and Peritoneal Dialysis Market.
Asia Pacific Hemodialysis and Peritoneal Dialysis Market
Segmental Coverage
Asia Pacific Hemodialysis and Peritoneal Dialysis Market – By End Use
Based on end use, the Asia Pacific Hemodialysis and Peritoneal Dialysis Market is split into home-based and hospital-based segments. The hospital-based segment accounts for a higher market share owing to the growing preference of patients opting for in-patient dialysis and treatment. The availability of qualified and experienced healthcare professionals directly contributes to the growth of hospital-based dialysis. However, the home-based segment is anticipated to register a faster growth rate over the period in analysis owing to the rising adoption of advanced technologies, such as IoT.
Sample Request @ https://www.blueweaveconsulting.com/report/asia-pacific-hemodialysis-and-peritoneal-dialysis-market/report-sample
Asia Pacific Hemodialysis and Peritoneal Dialysis Market – By Country
The in-depth research report on the Asia Pacific Hemodialysis and Peritoneal Dialysis Market covers a number of country-specific markets, including China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, and the rest of APAC. China dominates the Asia Pacific Hemodialysis and peritoneal dialysis market owing to the high presence of leading pharmaceutical and biotechnology companies in the country. The large population and low birth rates are leading to a rapidly aging population and rising cases of kidney failure, which is anticipated to boost the demand for hemodialysis and peritoneal dialysis products and services over the forecast period.
Competitive Landscape
Major players operating in the Asia Pacific Hemodialysis and Peritoneal Dialysis Market include Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd., Nipro Corp., Nikkiso Co., Ltd, NxStage Medical, Inc., DaVita Inc, Mitra Industries, Angiplast Private Limited, and JMS Co. Ltd. These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Asia Pacific Hemodialysis and Peritoneal Dialysis Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Asia Pacific Hemodialysis and Peritoneal Dialysis Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: April 2024
The growing prevalence of chronic kidney disease (CKD) and governments’ initiatives on strengthening their healthcare sector are expected to boost the growth of Asia Pacific Hemodialysis and Peritoneal Dialysis Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- Global Healthcare Payer Services Market Size Booming to Touch USD 125 Billion by 2029
- Saudi Arabia Solid Tumor Testing Market to Boom at Steady CAGR of 6.1% During 2023–2029
- India Dietary Supplements Market Size Zooming 2.6X at Robust CAGR of 14.7% to Touch USD 13.1 Billion by 2029
- Global Electrophysiology Market is All Set to Boom: Projected to Reach USD 12.10 Billion by 2027
- Global Cardiopulmonary Stress Testing Systems Market Size Expands to Touch USD 8.9 Billion by 2029